New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies ...
"Beta Thalassemia Market"In 2020, there are more than 900 beta-thalassemia major patients and more than 200 beta-thalassemia intermedia patients living in the UK. Emerging therapies for Beta ...
Around 5.2% of the global population carries abnormal hemoglobin genes. Each year, 300,000 to 500,000 children are born with severe hemoglobinopathies worldwide, with approximately 80% of these cases ...
The groundbreaking treatment can now also be used to treat transfusion-dependent beta thalassemia in people 12 and older. Like sickle cell, beta thalassemia is an inherited blood disorder. The FDA’s ...
New York, USA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight The thalassemia market is primarily ...
CLEVELAND, Ohio -- Cleveland Clinic Children’s Hospital is among the first in the country to use a new gene therapy to treat patients with thalassemia, a genetic blood disorder that affects the ...
COIMBATORE: About 14 districts in Tamil Nadu have received 20 new mobile medical units (MMUs) under the National Health ...
Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback